Loading organizations...

§ Private Profile · 2 Thermo Fisher Way Oakwood Village, Ohio 44146
ViewRay is a technology company.
ViewRay manufactures and markets the MRIdian system, an MRI-guided radiation therapy platform. This technology enables clinicians to simultaneously visualize and deliver radiation treatment to cancer patients, providing real-time anatomical imaging. It facilitates precise targeting and adaptive therapy during the session, addressing tumor motion and anatomical changes for enhanced accuracy.
Founded in 2004, ViewRay emerged from the insight that conventional radiation therapy lacked real-time imaging for dynamic targets. The company was established to integrate diagnostic-quality MRI with therapeutic radiation delivery, aiming for unprecedented precision in oncology. This concept led to a system combining magnetic resonance imaging directly with a radiation delivery device.
Oncology centers and hospitals worldwide utilize ViewRay’s MRIdian for cancer treatment, leveraging its adaptive, personalized care capabilities. The company’s vision focuses on transforming cancer treatment by offering clinicians superior visualization and control, improving patient outcomes. ViewRay aims to set new standards for precision radiation therapy through continuous technological advancement.
ViewRay has raised $255.3M across 10 funding rounds.
ViewRay has raised $255.3M in total across 10 funding rounds.
ViewRay has raised $255.3M across 10 funding rounds. Most recently, it raised $50.0M Debt in June 2015.
ViewRay is a medical technology company that develops MRI-guided radiation therapy systems (the MRIdian family) to enable real‑time soft‑tissue imaging during radiation delivery, improving precision of cancer treatments and enabling on‑table adaptive planning[5][6].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech & Clinical Landscape
Quick Take & Future Outlook
Sources used: company and clinical coverage noting MRIdian product, FDA clearances/patents, clinical deployments, and company expansion[1][3][5][6][2].
ViewRay has raised $255.3M in total across 10 funding rounds.
ViewRay's investors include CRG, Aisling Capital, Cowealth Medical Holding, F-Prime Capital, Kearny Venture Partners, OrbiMed, Endeavor Venture Funds, James Barrett, Siemens Venture Capital, Siemens, Andrew Jay, Josh Bilenker.